Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$9,735,448
+$2,191,808 QoQ
Shares Held
38,688
+11.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#935
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$25,164
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Venture Visionary Partners LLC holds $76,580,519 across 12 Drug Manufacturers - General names. ABBV ranks #4 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,155 | $16,977,933 | |
| 2 | JNJ |
Johnson & Johnson
|
65,476 | $16,628,939 | |
| 3 | AMGN |
Amgen Inc
|
42,758 | $15,483,526 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
38,688 | $9,735,448 | |
| 5 | MRK |
Merck & Co., Inc.
|
45,543 | $5,852,275 | |
| 6 | PFE |
Pfizer Inc
|
161,492 | $3,888,727 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
54,007 | $3,111,883 | |
| 8 | NVS |
Novartis AG
|
9,396 | $1,472,541 |
All Filings in ABBV
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,164 | 100 | Call | Sole | 2026-07-27 | |
| 2026-06-30 | $9,735,448 | 38,688 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $21,749 | 100 | Put | Sole | 2026-05-14 | |
| 2026-03-31 | $7,543,640 | 34,685 | Shares | Sole | 2026-05-14 | |
| 2026-03-31 | $21,749 | 100 | Call | Sole | 2026-05-14 | |
| 2025-12-31 | $7,644,132 | 33,455 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $22,849 | 100 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $45,698 | 200 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $23,154 | 100 | Call | Sole | 2025-10-06 | |
| 2025-09-30 | $7,753,348 | 33,486 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $6,639,627 | 35,770 | Shares | Sole | 2025-07-17 | |
| 2025-06-30 | $18,562 | 100 | Call | Sole | 2025-07-17 | |
| 2025-03-31 | $83,808 | 400 | Call | Sole | 2025-05-14 | |
| 2025-03-31 | $9,294,935 | 44,363 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,295,924 | 46,685 | Shares | Sole | 2025-07-14 | |
| 2024-09-30 | $8,840,784 | 44,768 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $7,725,946 | 45,044 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,077,409 | 44,357 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $6,957,688 | 44,897 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $6,633,468 | 44,502 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $6,060,290 | 44,981 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $7,011,323 | 43,994 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $6,960,542 | 43,070 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,879,471 | 43,808 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,500,416 | 42,442 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $6,749,125 | 41,633 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $9,053,521 | 66,865 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $6,828,063 | 63,299 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $6,673,356 | 59,245 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $6,034,238 | 55,759 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $3,637,206 | 33,945 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $1,012,803 | 11,563 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $949,891 | 9,675 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $543,234 | 7,130 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||